IIT Kanpur researchers, led by Professor Arun K Shukla, used cryo-EM to uncover the molecular basis of the atypical immune ...
Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and ...
By Beatriz Carpallo Porcar, Andrés Ráfales Perucha, Daniel Sanjuán Sánchez, José Lesmes Poveda López and Paula Cordova Alegre ...
Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and ...
As heart disease is increasingly recognised in younger women, incorporating menstrual history into cardiovascular assessment ...
Cells have evolved careful checks to ensure DNA is copied only once, but how they switch on replication at the right moment has been the focus of a 30-year research question. New work from the Crick ...
Employment agencies are calling for a full assessment of the economic and industry-wide implications of the proposed ...
Splatoon has always featured single-player campaigns, but they’ve never been the focus. Often they’re glorified tutorials, ...
Remepy, a pioneer in Hybrid Drugs™, today announced the publication of new mechanistic findings in npj Parkinson's Disease (Nature Portfolio). The study provides insight, for the first time, into ...